TC-5214 as Augmentation Therapy in Patients With Refractory Hypertension

NCT00899977 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

1

Enrollment

INDUSTRY

Sponsor class

Stopped Business reasons

Conditions

Refractory Hypertension

Interventions

DRUG: Placebo
DRUG: TC-5214

Sponsor

Targacept Inc.